Akero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 29, 2024 at 07:16 am EST
Akero Therapeutics, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 55.19 million compared to USD 23.06 million a year ago. Basic loss per share from continuing operations was USD 0.99 compared to USD 0.49 a year ago.
For the full year, the company reported net loss was USD 151.76 million compared to USD 112.03 million a year ago. Basic loss per share from continuing operations was USD 2.89 compared to USD 2.87 a year ago.